Avanos Medical Inc. (AVNS)
NYSE: AVNS
· Real-Time Price · USD
11.76
0.21 (1.82%)
At close: Sep 26, 2025, 3:59 PM
11.59
-1.43%
After-hours: Sep 26, 2025, 06:29 PM EDT
Avanos Medical Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|
| Corporate Other Revenue | 11.3M | 10.2M |
| Corporate Other Revenue Growth | +10.78% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 79M | 77.1M | 81.1M | 69M | 73.2M | 80.4M | 66M | 63.9M | 79.2M | 78.4M | 78.3M | 78.1M | 82.2M | 85.7M | 71M | 71.9M | 68.3M | 73.1M | 51.7M | 75.4M | 61.6M | 75.5M | 95.9M | 80.7M | 70M | 76.3M | 74.7M | 80.4M | 75.8M | 83.5M | 75.4M | 76.4M | 79.4M | 98.2M | 110.1M | 89.3M | 107.9M | 92.8M | 98.3M | 97.2M | 105.8M | 97.2M |
| Selling, General, and Administrative Revenue Growth | +2.46% | -4.93% | +17.54% | -5.74% | -8.96% | +21.82% | +3.29% | -19.32% | +1.02% | +0.13% | +0.26% | -4.99% | -4.08% | +20.70% | -1.25% | +5.27% | -6.57% | +41.39% | -31.43% | +22.40% | -18.41% | -21.27% | +18.84% | +15.29% | -8.26% | +2.14% | -7.09% | +6.07% | -9.22% | +10.74% | -1.31% | -3.78% | -19.14% | -10.81% | +23.29% | -17.24% | +16.27% | -5.60% | +1.13% | -8.13% | +8.85% | n/a |
| Research and Development Revenue | 5.8M | 5.4M | 5.7M | 7.2M | 6.3M | 7M | 6.8M | 6.1M | 6.8M | 7.9M | 7.5M | 7.3M | 8M | 7.8M | 7.6M | 8.4M | 8M | 8.3M | 9.6M | 8.2M | 7.7M | 9.4M | 8.4M | 9.6M | 9.5M | 10.2M | 10.6M | 10.5M | 10.8M | 9.9M | 12.1M | 9.6M | 9.2M | 8M | 12M | 10.9M | 9.5M | 8.7M | 9.8M | 10.2M | 6.3M | 6M |
| Research and Development Revenue Growth | +7.41% | -5.26% | -20.83% | +14.29% | -10.00% | +2.94% | +11.48% | -10.29% | -13.92% | +5.33% | +2.74% | -8.75% | +2.56% | +2.63% | -9.52% | +5.00% | -3.61% | -13.54% | +17.07% | +6.49% | -18.09% | +11.90% | -12.50% | +1.05% | -6.86% | -3.77% | +0.95% | -2.78% | +9.09% | -18.18% | +26.04% | +4.35% | +15.00% | -33.33% | +10.09% | +14.74% | +9.20% | -11.22% | -3.92% | +61.90% | +5.00% | n/a |